Epigenomics 2025

2 papers

Top Research Directions

The 4 research directions with Epigenomics 2025 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Epigenetic and Metabolic Memory of Cellular Stress150.0%
2Epigenome Wide Association Studies of Complex Traits150.0%
3False Discovery Rate Control for High Dimensional Data150.0%
4Tissue Specific Divergence in Peripheral Biomarkers150.0%

Download all directions as CSV

Institutions

Institutions credited by Epigenomics 2025 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 1 credited papers.

#InstitutionPapersShare
1045ney286 1100.0%
205hsqsk33 1100.0%
3Helsinki University Hospital 1100.0%
4Max Planck Institute of Psychiatry 1100.0%
5Norwegian University of Science and Technology 1100.0%
6Tampere University 1100.0%
7University of Helsinki 1100.0%
8University of Oulu 1100.0%

Download all institutions as CSV

About this data

Papers. Epigenomics 2025 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 2 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Epigenomics 2025”, https://lacuna.tiptreesystems.com/venue/epigenomics/2025.

Top Authors

AuthorPapers
Kirsi Hannele Pietiläinen1

Papers

Title
Blood and adipose tissue DNA methylation in adults born preterm with a very low birth weight – a sibling comparison study
The NEAT1/miR-124-3p/CCL2 axis in chronic kidney disease progression: integrated bioinformatics analysis and experimental validation